ArticleClinical pharmacology and therapeutics2025

Characteristics of Drugs from Non-Global Companies for Hematologic Malignancies and Impact on Global Regulatory Approval.

Kensuke Matsuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.